NOAC Antidotes: Reversal Strategies for Direct Oral Anticoagulants (DOACs) Introduction Non–vitamin K antagonist oral anticoagulants (NOACs), also known as DOACs, are widely used for stroke prevention in atrial fibrillation and treatment of venous thromboembolism. Despite their favorable safety profile compared to warfarin, major bleeding and urgent procedural needs require rapid reversal strategies. --- Classification of NOACs Direct Thrombin Inhibitor Dabigatran Factor Xa Inhibitors Rivaroxaban Apixaban Edoxaban --- Specific Antidotes 1. Dabigatran Reversal Antidote: Idarucizumab Mechanism: Monoclonal antibody fragment that binds dabigatran with very high affinity Dose: 5 g IV (2 × 2.5 g boluses) Onset: Immediate Indications: Life-threatening bleeding Emergency surgery --- 2. Factor Xa Inhibitor Reversal Antidote: Andexanet alfa Mechanism: Recombinant modified factor Xa decoy protein Targets: Rivaroxaban, Apixaban (limited data for Edoxaban) Administration: Bolus + infusion (dose dep...
Dr. Usman's Cardiology Notes
Cardiology Notes: Clinical Cases including ECG, Echocardiography, Cath, and MOCK Exams to sharpen your cardiology data interpretation skills. Healthcare is stressful!!! Learning cardiology shouldn't be !!!